Page 1589 - Small Animal Internal Medicine, 6th Edition

Index 1561

Hepatobiliary disease (Continued) High portal pressure, disorders Hyperadrenocorticism (Continued) Hyperparathyroidism
change in fecal color and, 525–527 associated with, 609–612 signs of, 879–880 classification of, 758
treatment of, 882–883
change in liver size and, 524–525, 525t High-density lipoproteins, 908 description of, 654t–655t, 741t primary, 758–763
VetBooks.ir in dogs, 584–619 Higher-protein diets, 904 diagnosis of, 1249–1250 definition of, 758–759
High-dose dexamethasone suppression
coagulopathies in, 527–529
clinical signs of, 759, 760b
test, 864–865, 866t, 871
characteristics of, 563t
diagnosis of, 760–761, 762f
in dogs, 857–878
chronic hepatitis. see Chronic
etiology of, 758–760
hepatitis, canine High-molecular-weight kininogen, abdominal ultrasonography of, differential diagnosis of, 924, 925f
1387–1388, 1393
862–864, 862b, 863f–865f
congenital vascular disorders, Hilar lymphadenopathy, 366f, 926 adrenocortical tumors, 857–858, hypercalcemia caused by, 761t
603–612 Hindlimb paresis, 225 858f physical examination of, 760
copper storage disease, 595–598 Histamine-2 (H 2 ) receptor antagonists, clinical features of, 858–871 prognosis for, 763
general considerations for, 584 439, 439t, 701 clinical pathology of, 861–862, signalment, 759
drugs used in, 643t–648t Histiocytic ulcerative colitis, 495 861b treatment of, 761–763
gastrointestinal signs with, 518–519, Histoplasma capsulatum, 1503t, 1510, diagnostic evaluation of, 861 secondary, 758
519b 1510f etiology of, 857–858 Hyperphosphatemia, 691, 929–930, 929b
hepatic encephalopathy in, 522–524 Histoplasmosis, 483–484, 484f, imaging of, 862–864, 862b Hyperpigmentation, 1283
jaundice in, 525–527, 526f, 528f 1510–1511 medical complications of, 860–861, Hyperplasia
polyuria and polydipsia in, 519–522 HMG-CoA reductase inhibitors, 860b benign prostatic, 1001–1003, 1002f,
protein-calorie malnutrition, 529–530, 913–914 occult hyperadrenocorticism, 1034t–1036t
529f Hock, arthrocentesis method in, 1191f 878 cytologic features of, 1259
Hepatobiliary infections, in cats, Holmium:YAG laser lithotripsy, 714, 714f physical examination of, 860t Hyperplastic lymphadenopathy,
579–580, 580b Holosystolic murmurs, 9–10, 114 pituitary macrotumor syndrome, 1263–1264
Hepatobiliary system Holosystolic timing, 11 859–860, 860f Hyperplastic splenomegaly, 1411, 1412t
diagnostic approach for, 531–545 Holter monitoring, 49–50 pituitary-dependent Hyperpnea, 4
diagnostic tests for, 531–560 description of, 78 hyperadrenocorticism, 857, Hyperprogesteronism, 748t
abdominocentesis, 543–544, 544t ventricular ectopy detection using, 858f–859f, 863f, 869f, 876f Hyperproteinemia, 1298, 1420–1422
coagulation tests, 543 143–144 prognosis for, 877–878 Hypersensitivity reactions, 1281
complete blood count, 538 Homocysteine, 1364 signalment for, 858 Hypersthenuria, 663
computed tomography, 553, 553f Hookworms, 487, 1536 signs of, 858–859, 860t Hypertension
fecal evaluation, 545 Hormones, 1273, 1273b treatment, 871–877 amlodipine besylate for, 215, 217t
liver cytology, 553, 554f Horner syndrome, 1089–1091, adrenalectomy, 875–876 angiotensin-converting enzyme
magnetic resonance imaging, 553 1089f–1090f, 1089b, 1111f hypophysectomy, 877 inhibitors for, 215, 217t
plasma ammonia concentration, Howell-Jolly bodies, 1345t ketoconazole, 875 antihypertensive drugs for, 215, 217t
536–537 Human chorionic gonadotropin (hCG), mitotane, 872–875, 874b cardiomegaly secondary to, 213
plasma protein C activity, 537 1034t–1036t pituitary irradiation, 876–877, in chronic kidney disease, 698
scintigraphy, 553 Human intravenous immunoglobulin, 876f clinical features of, 213
serum albumin concentration, 1225t, 1228, 1236–1237, 1243, trilostane, 871–872, 872f complications of, 213b
537–538 1255t–1256t endocrine alopecia caused by, 748t diabetes mellitus and, 830
serum bile acid concentration, Human toxoplasmosis, 1524b hypertriglyceridemia associated with, diagnosis of, 213–214
535–536, 535b Humidification, 342 910 dietary salt restriction for, 215–216
serum bilirubin concentration, Humoral hypercalcemia of malignancy, hypothyroidism versus, 783–784 diseases associated with, 211–212,
534–535 760, 924 iatrogenic, 858, 870 212b
serum biochemistry, 541–542, Hyaline cast, 667–668, 667f occult, 878 echocardiographic findings, 213–214
541t–542t Hydralazine, 62b, 63 pituitary-dependent etiology of, 211–212
serum cholesterol concentration, chronic heart failure treated with, 64t, in cats, 869f, 879f–880f general considerations for, 211–219
538 71, 147 in dogs, 857, 858f–859f, 863f, 869f, in glomerular disease, 685
serum liver enzyme activities, dilated cardiomyopathy treated with, 876f hyperthyroidism and, 791
532–534 147 Hyperbilirubinemia, 1231, 1489 idiopathic, 211–212
serum urea nitrogen concentration, hypertension treated with, 217t Hypercalcemia, 48, 49b, 761t, 923–927, mild, 211
538 Hydrocephalus, 1078–1080, 1078f–1079f 1268, 1298 moderate, 211
status of, 532–534, 533t Hydrochlorothiazide, 64t, 67, 718 Hypercapnia, 385 ocular effects of, 212, 213b
survey radiography, 545–549, Hydrocodone bitartrate, 386t–388t Hypercholesterolemia, 685, 913 organs affected by, 211
546f–549f Hydrocortisone, 1222t Hyperchylomicronemia, 1162 pathophysiology of, 212
ultrasonography, 549–553, 549f, Hydromorphone, 386t–388t, 629t–630t Hypercoagulability, 223 portal
550t–551t, 551f–552f analgesic uses of, 227b Hyperechoic, defined, 19 chronic hepatitis and, 588
urinalysis, 544–545 stress relief using, 380t Hyperemesis gravidarum, 966–967 congestive splenomegaly caused by,
urinary bile acid concentration, Hydromyelia, 1155 Hypereosinophilic syndrome, 1377 1413
536 1α-Hydroxylase, 697 Hyperestrogenism, 747–748, 748t, 954, prognosis for, 215–217
Hepatocutaneous syndrome, 615–616, 17α-Hydroxyprogesterone caproate, 982–983 renal disease and, 211–212
616f 962–963 Hyperfiltration, 693–694, 694f severe, 211
Hepatocyte vacuolation, 616–617, 617f Hydroxyurea Hypergastrinemia, 701 treatment of, 215–217, 216b, 217t
Hepatocytes, feline, 564f chronic myelogenous leukemia treated Hyperglycemia Hypertensive crisis, 217t, 219
Hepatojugular (abdominojugular) reflux, with, 1319 clinical features of, 806 Hypertensive emergency, 218–219
5–6 erythrocytosis treated with, 116 etiology of, 806, 807b Hypertensive encephalopathy, 213, 1077
Hepatomegaly, 1342t polycythemia rubra vera treated with, transient stress-induced, 833 Hyperthyroidism, 654t–655t
Hepatosplenomegaly, 1314f 1369 Hyperhomocysteinemia, 223 in cats, 167–168, 788–800
Hepatoxicity, chemotherapy-induced, Hyoscyamine Hyperkalemia, 47–48, 49b, 50f, 690–691, carbimazole, 796t, 797
1285 in dogs, 90t–91t 919–921, 920b, 921t cervical ultrasound for, 794, 795f
Hepatozoon americanum, 154, 1430, dosage of, 90t–91t Hyperkinetic, defined, 5 chronic kidney disease with,
1440t, 1517 Hypalgesia, 1040–1041 Hyperlipidemia 790–791
Hepatozoon canis, 1517 Hyperadrenocorticism causes of, 909b clinical features of, 789
Hepatozoonosis, 1517–1518 acromegaly versus, 752 classification of, 909–910 clinical pathology of, 790–791
Heritable teratospermia, 1005 adrenal-dependent, 863f clinical features of, 910 diagnosis of, 791–794
Hernia in cats, 878–883 definition of, 908 etiology of, 788–789, 788f–789f
diaphragmatic. see Diaphragmatic adrenalectomy for, 883 diagnosis of, 910–911 gastrointestinal tract disorders and,
hernia clinical features of, 879–882, 879b in glomerular disease, 685 791
hiatal, 416, 456, 457f clinical pathology of, 880–881 HMG-CoA reductase inhibitors for, iatrogenic hypothyroidism and,
perineal, 504–505 description of, 878 913–914 790–791
Herpesvirus diagnosis of, 882 pathophysiology of, 908–909 iodine-restricted diet for, 796t,
feline. see Feline herpesvirus etiology of, 878 postprandial, 909 797–798
pregnancy loss and imaging of, 881 secondary, 909–910 methimazole for, 794, 796t
canine, 966 physical examination findings in, treatment of, 911–914, 912t oral antithyroid drugs for, 794–797
feline, 966 879–880, 879f Hypermagnesemia, 933 physical examination of, 789, 790t
Hetastarch, 515t–517t pituitary-adrenocortical axis tests, Hypermetria, 1074–1075, 1147f radioactive iodine for, 796t,
Heterobilharzia, 491 881–882, 881t Hypermetric gait, 1038–1039, 1074–1075 799–800, 799f
Hiatal hernia, 416, 456, 457f prognosis for, 883 Hypernatremia, 915–917, 916b, 917t serum TSH concentration, 793